Metraipolis › archive › dc_ca3d3cee5a6f

Impact of concomitant use of pazopanib and gastric acid suppressants on progression-free survival and safety in patients with sarcoma: a retrospective study — Europe PMC PMID:40826486

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40826486
DOI
10.1186/s40780-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-10T13:14:38.684Z
SHA-256 of the archived text
95397cf89bec8fcd02deaa7c53de5e0611c0735d4195425a89494cdd4e33434a
Stable URL of this page
https://metraipolis.com/documento/dc_ca3d3cee5a6f

How to cite

Impact of concomitant use of pazopanib and gastric acid suppressants on progression-free survival and safety in patients with sarcoma: a retrospective study — Europe PMC PMID:40826486 — Europe PMC (en), https://europepmc.org/article/MED/40826486 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca3d3cee5a6f (Metraipolis archive dc_ca3d3cee5a6f, sha256 95397cf89bec8fcd02deaa7c53de5e0611c0735d4195425a89494cdd4e33434a)
BibTeX
@misc{dcca3d3cee5a6f,
  title = {Impact of concomitant use of pazopanib and gastric acid suppressants on progression-free survival and safety in patients with sarcoma: a retrospective study — Europe PMC PMID:40826486},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40826486},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca3d3cee5a6f; sha256 95397cf89bec8fcd02deaa7c53de5e0611c0735d4195425a89494cdd4e33434a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40826486. Agents can read the archived copy with the MCP tool read_document.